Integrated proteomic and phosphoproteomic analysis reveal novel targets and suggest rationale for ibrutinib efficacy in UM-CLL

ABSTRACT: n order to decipher the underlying mechanisms we aimed to analyze and compare the global phosphoproteome of UM-CLL and M-CLL cells.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell, B-lymphocyte

DISEASE(S): Chronic Lymphocytic Leukemia

SUBMITTER: René Zahedi  

LAB HEAD: Rene Zahedi

PROVIDER: PXD016421 | Pride | 2022-01-14

REPOSITORIES: Pride